Labeler
Alembic Pharmaceuticals Inc. NDC Codes
Alembic Pharmaceuticals Inc. lists 500 finished drug products in the FDA NDC Directory under NDC labeler code 62332.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Diltiazem Hydrochloride, Amlodipine and Atorvastatin, carbidopa, levodopa and entacapone, Dasatinib, Rivaroxaban, Telmisartan and Amlodipine, Lamotrigine, Carbamazepine, Duloxetine Hydrochloride, Paroxetine, Triamcinolone Acetonide, sacubitril and valsartan, Prucalopride, Tretinoin, Bosutinib
- Active ingredients
- Amlodipine besylate, Diltiazem hydrochloride, Atorvastatin calcium trihydrate, Carbidopa, Levodopa, Entacapone, Dasatinib, Telmisartan, Lamotrigine, Carbamazepine, Rivaroxaban, Duloxetine hydrochloride
- NDC labeler codes
- 62332
- Strengths (from the 100 most recently listed products)
- Amlodipine besylate 5 mg/1; Amlodipine besylate 10 mg/1; Entacapone 200 mg/1; Diltiazem hydrochloride 120 mg/1; Amlodipine besylate 2.5 mg/1; Atorvastatin calcium trihydrate 40 mg/1; Atorvastatin calcium trihydrate 10 mg/1; Atorvastatin calcium trihydrate 20 mg/1; Methotrexate sodium 25 mg/mL; Telmisartan 80 mg/1; Telmisartan 40 mg/1; Carbamazepine 200 mg/1; Doxorubicin hydrochloride 2 mg/mL; Atorvastatin calcium trihydrate 80 mg/1; Diltiazem hydrochloride 180 mg/1; Olopatadine hydrochloride 7 mg/mL; Ciprofloxacin .5 mg/.25mL; Valganciclovir hydrochloride 50 mg/mL; Ciprofloxacin hydrochloride 3 mg/mL; Dexamethasone 1 mg/mL
- Dosage forms
- Tablet, Film coated, Capsule, Extended release, Tablet, Capsule, Delayed release, Tablet, Film coated, Extended release, Tablet, Orally disintegrating, Injection, Suspension, Solution/ drops, Powder, For solution, Suspension/ drops, Cream, Injection, Solution, Injection, Injection, Suspension, Liposomal, Solution, Gel, For suspension, Capsule, Tablet, Coated, Emulsion, Injection, Emulsion, Kit, Ointment
- Routes
- Oral, Intramuscular, Intravenous, Subcutaneous, Ophthalmic, Topical, Intra-articular, Auricular (Otic), Intrathecal, Cutaneous
- Drug classes (FDA established)
- Calcium Channel Blocker, Dihydropyridine Calcium Channel Blocker, HMG-CoA Reductase Inhibitor, Mood Stabilizer, Kinase Inhibitor, Angiotensin 2 Receptor Blocker, Aromatic Amino Acid, Catechol-O-Methyltransferase Inhibitor, Corticosteroid, Anti-epileptic Agent, Factor Xa Inhibitor, Serotonin and Norepinephrine Reuptake Inhibitor, Serotonin Reuptake Inhibitor, Proton Pump Inhibitor, Neprilysin Inhibitor, Fluoroquinolone Antibacterial, Serotonin-4 Receptor Agonist, Retinoid, Folate Analog Metabolic Inhibitor, Sodium-Glucose Cotransporter 2 Inhibitor, Serotonin-1b and Serotonin-1d Receptor Agonist, P2Y12 Platelet Inhibitor, Anthracycline Topoisomerase Inhibitor, Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker, Histamine-1 Receptor Antagonist, Histamine-1 Receptor Inhibitor, Mast Cell Stabilizer, Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor, Nucleoside Analog Antiviral, Central alpha-2 Adrenergic Agonist, Sulfone, Neuraminidase Inhibitor, Endothelin Receptor Antagonist, Sphingosine 1-phosphate Receptor Modulator, Prostaglandin Analog, Aminoglycoside Antibacterial, Vitamin K, Warfarin Reversal Agent, Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor, Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor, Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 215 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Olopatadine Hydrochloride | Olopatadine hydrochloride 7 mg/mL | SolutionOphthalmic | 62332-774 | 62332-0774-25 | — |
| Ciprofloxacin Oticciprofloxacin | Ciprofloxacin .5 mg/.25mL | Solution/ dropsAuricular (Otic) | 62332-168 | 62332-0168-25 | — |
| Valganciclovir | Valganciclovir hydrochloride 50 mg/mL | Powder, For solutionOral | 62332-754 | 62332-0754-31 | — |
| Ciprofloxacin and Dexamethasone | Ciprofloxacin hydrochloride 3 mg/mL; Dexamethasone 1 mg/mL | Suspension/ dropsAuricular (Otic) | 62332-776 | 62332-0776-75 | — |
| clonidine hydrochloride | Clonidine hydrochloride .05 mg/1 | TabletOral | 62332-169 | 62332-0169-1062332-0169-3062332-0169-31+3 more | — |
| Prucalopride | Prucalopride succinate 2 mg/1 | Tablet, Film coatedOral | 62332-078 | 62332-0078-30 | — |
| Prucalopride | Prucalopride succinate 1 mg/1 | Tablet, Film coatedOral | 62332-077 | 62332-0077-30 | — |
| Dapsone | Dapsone 50 mg/g | GelTopical | 62332-551 | 62332-0551-3062332-0551-6062332-0551-90 | — |
| Oseltamivir Phosphate | Oseltamivir phosphate 6 mg/mL | For suspensionOral | 62332-769 | 62332-0769-60 | — |
| Tretinoin | Tretinoin .5 mg/g | CreamTopical | 62332-808 | 62332-0808-2062332-0808-45 | — |
| Macitentan | Macitentan 10 mg/1 | Tablet, Film coatedOral | 62332-373 | 62332-0373-30 | — |
| Bosutinib | Bosutinib 100 mg/1 | Tablet, Film coatedOral | 62332-311 | 62332-0311-35 | — |
| Bosutinib | Bosutinib 500 mg/1 | Tablet, Film coatedOral | 62332-312 | 62332-0312-30 | — |
| Fingolimod | Fingolimod hydrochloride .5 mg/1 | CapsuleOral | 62332-228 | 62332-0228-1062332-0228-30 | — |
| Methotrexate | Methotrexate sodium 25 mg/mL | Injection, SolutionIntramuscular, Intravenous, Subcutaneous | 62332-711 | 62332-0711-05 | — |
| Methotrexate | Methotrexate sodium 25 mg/mL | Injection, SolutionIntramuscular, Intrathecal, Intravenous, Subcutaneous | 62332-712 | 62332-0712-01 | — |
| Duloxetine Hydrochlorideduloxetine | Duloxetine hydrochloride 60 mg/1 | Capsule, Delayed releaseOral | 62332-280 | 62332-0280-3062332-0280-9062332-0280-91 | — |
| Duloxetine Hydrochlorideduloxetine | Duloxetine hydrochloride 20 mg/1 | Capsule, Delayed releaseOral | 62332-278 | 62332-0278-3062332-0278-6062332-0278-90+1 more | — |
| Duloxetine Hydrochlorideduloxetine | Duloxetine hydrochloride 30 mg/1 | Capsule, Delayed releaseOral | 62332-279 | 62332-0279-3062332-0279-9062332-0279-91 | — |
| Dapagliflozin | Dapagliflozin 5 mg/1 | Tablet, Film coatedOral | 62332-392 | 62332-0392-3062332-0392-9062332-0392-91 | — |
| Dapagliflozin | Dapagliflozin 10 mg/1 | Tablet, Film coatedOral | 62332-393 | 62332-0393-3062332-0393-9062332-0393-91 | — |
| Telmisartan and Amlodipine | Telmisartan 80 mg/1; Amlodipine besylate 5 mg/1 | TabletOral | 62332-186 | 62332-0186-1062332-0186-30 | — |
| Telmisartan and Amlodipine | Telmisartan 40 mg/1; Amlodipine besylate 5 mg/1 | TabletOral | 62332-184 | 62332-0184-1062332-0184-30 | — |
| Telmisartan and Amlodipine | Telmisartan 40 mg/1; Amlodipine besylate 10 mg/1 | TabletOral | 62332-185 | 62332-0185-1062332-0185-30 | — |
| Telmisartan and Amlodipine | Telmisartan 80 mg/1; Amlodipine besylate 10 mg/1 | TabletOral | 62332-187 | 62332-0187-1062332-0187-30 | — |
| Paroxetine | Paroxetine hydrochloride hemihydrate 12.5 mg/1 | Tablet, Film coated, Extended releaseOral | 62332-766 | 62332-0766-3062332-0766-91 | — |
| Lamotrigine | Lamotrigine 100 mg/1 | Tablet, Orally disintegratingOral | 62332-772 | 62332-0772-1062332-0772-30 | — |
| Lamotrigine | Lamotrigine 25 mg/1 | Tablet, Orally disintegratingOral | 62332-770 | 62332-0770-1562332-0770-30 | — |
| Lamotrigine | Lamotrigine 50 mg/1 | Tablet, Orally disintegratingOral | 62332-771 | 62332-0771-1562332-0771-30 | — |
| Lamotrigine | Lamotrigine 200 mg/1 | Tablet, Orally disintegratingOral | 62332-773 | 62332-0773-1062332-0773-30 | — |
| carbidopa, levodopa and entacapone | Carbidopa 31.25 mg/1 + 2 more ingredients | Tablet, Film coatedOral | 62332-798 | 62332-0798-3162332-0798-91 | — |
| carbidopa, levodopa and entacapone | Carbidopa 12.5 mg/1 + 2 more ingredients | Tablet, Film coatedOral | 62332-795 | 62332-0795-3162332-0795-91 | — |
| carbidopa, levodopa and entacapone | Carbidopa 18.75 mg/1 + 2 more ingredients | Tablet, Film coatedOral | 62332-796 | 62332-0796-3162332-0796-91 | — |
| carbidopa, levodopa and entacapone | Carbidopa 25 mg/1 + 2 more ingredients | Tablet, Film coatedOral | 62332-797 | 62332-0797-3162332-0797-91 | — |
| carbidopa, levodopa and entacapone | Carbidopa 37.5 mg/1 + 2 more ingredients | Tablet, Film coatedOral | 62332-799 | 62332-0799-3162332-0799-91 | — |
| carbidopa, levodopa and entacapone | Carbidopa 50 mg/1 + 2 more ingredients | Tablet, Film coatedOral | 62332-800 | 62332-0800-3162332-0800-91 | — |
| Pivyapivmecillinam | Pivmecillinam hydrochloride 185 mg/1 | Tablet, CoatedOral | 62332-966 | 62332-0966-09 | — |
| Difluprednatedifluprednate ophthalmic | Difluprednate .5 mg/mL | EmulsionOphthalmic | 62332-750 | 62332-0750-05 | — |
| Travoprost ophthalmic solutiontravoprost ophthalmic | Travoprost .04 mg/mL | Solution/ dropsOphthalmic | 62332-625 | 62332-0625-0262332-0625-05 | — |
| Loteprednol etabonate and Tobramycin | Loteprednol etabonate 5 mg/mL; Tobramycin 3 mg/mL | Suspension/ dropsOphthalmic | 62332-801 | 62332-0801-0562332-0801-10 | — |
| Diltiazem Hydrochloride | Diltiazem hydrochloride 60 mg/1 | Tablet, Film coatedOral | 62332-782 | 62332-0782-3162332-0782-71 | — |
| Diltiazem Hydrochloride | Diltiazem hydrochloride 30 mg/1 | Tablet, Film coatedOral | 62332-781 | 62332-0781-3162332-0781-71 | — |
| Diltiazem Hydrochloride | Diltiazem hydrochloride 90 mg/1 | Tablet, Film coatedOral | 62332-783 | 62332-0783-3162332-0783-71 | — |
| Diltiazem Hydrochloride | Diltiazem hydrochloride 120 mg/1 | Tablet, Film coatedOral | 62332-784 | 62332-0784-3162332-0784-71 | — |
| Dexlansoprazole | Dexlansoprazole 30 mg/1 | Capsule, Delayed releaseOral | 62332-823 | 62332-0823-3062332-0823-90 | — |
| Dexlansoprazole | Dexlansoprazole 60 mg/1 | Capsule, Delayed releaseOral | 62332-824 | 62332-0824-3062332-0824-90 | — |
| Dasatinib | Dasatinib 20 mg/1 | Tablet, Film coatedOral | 62332-684 | 62332-0684-60 | — |
| Dasatinib | Dasatinib 100 mg/1 | Tablet, Film coatedOral | 62332-688 | 62332-0688-30 | — |
| Dasatinib | Dasatinib 50 mg/1 | Tablet, Film coatedOral | 62332-685 | 62332-0685-60 | — |
| Dasatinib | Dasatinib 70 mg/1 | Tablet, Film coatedOral | 62332-686 | 62332-0686-60 | — |
Alembic Pharmaceuticals Inc.: common questions
- What is Alembic Pharmaceuticals Inc.'s NDC labeler code?
- 62332. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Alembic Pharmaceuticals Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.